the majority of studies conducted have examined adherence within a given disease state. Few have examined adherence across multiple conditions to determine whether associations between adherence and patient characteristics are consistent. Such information could be helpful in health systems such as ours to develop focused interventions. Therefore, to increase the understanding of medication adherence in our population, we examined adherence across multiple health conditions, examining associated patient and drug-related characteristics. The purpose of this paper is to report on the patient characteristics associated with adherence within this large integrated health system.
Methods

Study Sample
This study was conducted within a large, Midwestern, integrated health system serving over 750,000 patients. The study sample was comprised of all patients age 18 and over with at least one of eight medical conditions that included asthma/chronic obstructive pulmonary disease (COPD), cancer, depression, diabetes, hypercholesterolemia, hypertension, multiple sclerosis (MS), or osteoporosis. The conditions selected represented the most prevalent conditions treated.
It also included conditions with both low cost and high cost medication and conditions where most care is delivered through primary care, as well as conditions treated primarily through specialty care. To be eligible, patients were required to have a 12-month (allowing for an additional 15 days) record of prescription coverage and a minimum of two prescription fills for the medication used to treat one of the above-mentioned conditions.
Patients within the health system have a pharmacy benefit that is included in their health coverage. While medications are readily available at in-clinic pharmacies and through the health plan owned mail order pharmacy, patients can fill prescriptions at local pharmacies. were evaluated for each individual medication and deemed non-adherent to their regimen if they did not achieve the 80% level for any prescribed medications.
Data Sources and Variables
Age (categorized by decade) and race were obtained for all study subjects from clinical records located within the EMR. Co-morbidity was measured by a count of Charlson (0, 1, 2, 3+) comorbid conditions using two primary or secondary diagnosis codes located within the EMR Patient living area variables from the census that were used as proxies for patient SES included percentage of adults 25+ with a high school education, percentage of individuals living in poverty, and median family income. These census variables were summarized in quartiles.
Analysis
To illustrate the distribution of MPR values within each condition, MPRs were plotted for patients having one condition and on one drug. The proportion of patients adherent (MPR >80%)
to their medications was summarized by patient and living-area (census) characteristics.
Bivariate associations between drug adherence and patient and living area characteristics were examined and tested using contingency tables and chi-square tests to allow for the possibility of nonlinear patterns in multi-category variables. These summaries were computed using the population of patients who had only one of the eight conditions who also received only one medication for their single condition (n=15,334). This enabled examination of data with the least confounded population. The analyses were then repeated on the total population of patients (those with any number of the eight conditions under study), and any number of medications for those conditions (n=31,636). The data from this larger group of patients was also used in unconditional logistic regression analysis to examine predictors of adherence from the set of patient and living area characteristics.
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We examined data for patients with diabetes both including and excluding those who take insulin-only for treatment. For purposes of this paper, we included all diabetes patients. For asthma patients we included those on chronic medications, as we could not track medications used only "as needed".
Separate 
Results
Patient Demographics
Adherence by Condition
Within the 15,334 patient group, substantial variation in MPR was found by condition.
Hypertension, hyperlipidemia, osteoporosis, MS, and cancer had greater than 75% of patients considered adherent. Adherence rates for depression (62%), diabetes (51%), and asthma/COPD (33%) fell well below the 80% MPR threshold. This variation by condition was true for the total population as well, ranging from 32% to 75%. 
Adherence By Patient Characteristics
After examining adherence by condition, we then examined patterns of overall drug adherence by patient characteristics, within each specific condition. We did this for those with a single condition and then for those with multiple conditions. As findings for both groups were similar, we are presenting results for the total population (table 2) .
Overall, adherence rates were higher for those living in higher SES areas and for whites. Those in the lowest quartile of the living area variables (education, poverty, income) had lower drug adherence than those in other quartiles. When dividing age into quartiles, those in the lowest age 
Discussion
The issue of adherence to medication is a growing concern. The World Health Organization identified it as adding to the burden of disease, 11, 26 and Carolyn M. Clancy, MD, director of the Agency for Healthcare Research and Quality has declared "Medication adherence is America's new drug problem". 12 Further as the population ages and faces more chronic conditions, maintaining essential treatments is likely to be an increasing concern.
To address this issue, we conducted a study that examined adherence for eight conditions using patients with prescription coverage drawn from a large integrated health system. This allowed comparisons of adherence rates across conditions as well as an examination of patterns of correlates with adherence across conditions. What we found was relatively consistent with those 27, 28 While five of the eight conditions studied found 75% of patients adherent ( MPRs >0.80), higher than adherence rates reported by others, there remains room for improvement. 12 In an examination of randomized controlled trials of interventions for enhancing adherence, Haynes and colleagues 29 found that less than half of prescribed doses were taken by people prescribed self-administered medications. In another by Rasmussen, 30 focusing on lipid-lowering drugs, the rate of discontinuation was 38% after one year. In patients with hypertension, non-compliance to treatment ran between 15% to 54%. 31 Others have cited rates between 18% to 80%. 32, 33 Lafata, et al 34 conducted a retrospective cohort study to measure adherence over a 24-month period among patients in a setting much like our own. Using pharmacy claims to estimate MPRs, they found 43% of patients not maintaining their regimens after 14 months. 34 In another study examining drug therapies for osteoporosis, overall adherence was 52%. 35 A more recent study compared adherence and persistence across six chronic medication classes. 11 The investigators found adherence decreased with increasing age. The authors recommended focusing quality improvement efforts where non-adherence was found to be most costly. 11 While our focus was not on the same conditions or outcomes, we also believe it is essential to focus efforts on those conditions with the poorest adherence. In our integrated health system the conditions with the poorest adherence and biggest need for improvement were asthma (33%) and diabetes (51%). We also have clear evidence of patient characteristics shown to be Minorities were consistently less adherent. This may be secondary to drug-related issues.
Language barriers and cultural beliefs should be explored further to better understand their role in adherence. Generally, where differences were found by sex, it was most often men who were more adherent. It may be that women, who are frequently the primary care-givers, spend less time and energy taking care of themselves. Patient education surrounding the importance of continuing needed medication may be worthy in our female population. Similarly, taking extra time with those on multiple medications, where adherence was lower, to ensure patients understand the importance of not treating one condition at the detriment of another, is essential.
We hypothesized that having readily available pharmacies in our medical clinics would result in better adherence than had been reported by others, but we found that this alone did not make the health system immune to non-adherence.
Limitations and Strengths
This study was conducted in a single health system, thus results may not be generalizable to all systems. However, the patterns of adherence were quite similar to what others have reported.
Secondly, we assumed that obtaining a prescription was equivalent to actually taking the medication. Thus, we may be presenting a more optimistic assessment than what is actually true.
There are multiple approaches to measuring medication adherence, and some might suggest that a different approach may be preferable. Hess, in comparing methods found all provided similar values. 18 Further, it was the method most used by others with databases similar to ours. While
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Our decision to include all diabetes patients may be questioned by some. Researchers have included insulin-only users 36, 37 and excluded them. 38 Some have used an adjusted MPR (multiplying by a factor of 1.5). 39 We examined the data in all manners for these individuals, and all results (51%-60% adherent), regardless of approach, indicated a need to boost adherence.
Another limitation was our use of contextual variables as a proxy for SES rather than using patient-level variables. We did not have direct access to such data and felt the proxy could provide needed insight. 25 Our exclusion criteria of omitting those whose prescriptions were for less than 28 days excluded slightly over 7% of the prescriptions, but we did not want to include those that may have been prescribed short-term treatment. More importantly, we eliminated those who were on a given medication for less than one year from our analyses. We did this to ensure we did not categorize anyone whose initial therapy did not work for them as non-adherent. Our goal was to focus on adherence patterns in patients attempting to take medications chronically. Our analysis presented the best case scenario for our health plan and still evidenced conditions where intervention is sorely needed.
There was also concern about not obtaining full information on patients obtaining $4 generic medications. Understanding the robustness of our pharmacy data has resulted in our pharmacy division monitoring what appears in our claims data and the level of potentially missing data.
Through internal, unpublished analysis, we have determined the various incentives programs have had small impact on the fills data within our health plan.
Despite the limitations, we believe we were able to obtain comprehensive records on both diagnoses and pharmacy data on a large number of patients and carefully track drug usage across multiple conditions. The findings have provided direction to the health plan on conditions warranting special attention. Efforts are currently being focused on asthma and diabetes patients (where adherence was the lowest). Both providers and pharmacists have been encouraged to stress the importance of patients taking their medications as prescribed. Pill containers are being offered to serve as reminders and the pharmacy division is looking at alternative ways to package medications for those on many and complicated regimens. In addition, extra efforts are being made for minority patients, especially our immigrant populations, to be certain they understand the benefits of the medications being prescribed
Conclusion
This study assessing medication adherence across eight diseases found variable adherence rates by condition and some conditions where rates were extremely low. In a population with prescription coverage offering multiple avenues with which to obtain medications, the findings pointed to the need to consider additional efforts to boost adherence rates. Further, the identification of patient characteristics associated with lower adherence has provided direction to begin to focus our efforts. 
